Beruflich Dokumente
Kultur Dokumente
preeclampsia
www.NursingMadeIncrediblyEasy.com
before pregnancy or before 20 weeks gestation, or when her BP remains high 12 weeks
after delivery. Some women may not be
aware that they have hypertension, so early
prenatal care is vital. If a womans BP is high
initially or if the expected decrease in BP
between 8 and 28 weeks gestation doesnt
occur, she must be monitored carefully for
chronic hypertension.
Preeclampsia is present when a previously normotensive woman develops increased
BP after 20 weeks gestation (140/90 mm Hg
or higher on two occasions, taken at least 6
hours apart).
In mild preeclampsia, a womans BP is
higher than 140/90 mm Hg, her urine protein is generally 1+ to 2+, liver enzymes may
be minimally elevated, and edema may or
may not be present.
In severe preeclampsia, a womans BP is
160/110 mm Hg or higher, with 3+ to 4+
proteinuria. Headaches, visual changes
(blurring or seeing spots), worsening edema,
hyperreflexia, decreased urine output, lab
results indicative of HELLP syndrome
(hemolysis, elevated liver enzymes, and a
low platelet count), and right upper quadrant or epigastric pain may be present. Right
upper quadrant painthought to be caused
by liver inflammationoften signifies
impending eclampsia.
Preeclampsia becomes eclampsia when the
patient experiences a grand mal seizure. She
may have only one or as many as 20. The
onset may occur before, during, or after labor.
Chronic hypertension with superimposed
preeclampsia or eclampsia is characterized
by a BP of greater than or equal to 140/90
mm Hg before the 20th week of pregnancy,
with superimposed proteinuria and with or
without signs of preeclampsia syndrome.
Gestational (or transient) hypertension
develops after 20 weeks gestation. Theres
March/April 2010 Nursing made Incredibly Easy! 21
Edema is no
longer a defining
symptom of
preeclampsia.
www.NursingMadeIncrediblyEasy.com
Management strategies
Monitor BP closely.
Monitor fetal heart rate continuously.
Monitor maternal serum magnesium levels as ordered (usually every 6 to 8 hours). Therapeutic levels are in the range of
4.8 to 9.6 mg/dL. Reflexes often disappear at levels of 8 to
12 mg/dL, respiratory depression occurs at 15 to 17 mg/dL,
and cardiac arrest occurs at levels above 30 mg/dL.
Assess patellar reflex. Loss of reflexes is often the first sign
of developing toxicity. Also assess for marked lethargy,
decreased level of consciousness, and hypotension.
Assess urine output.
Monitor the respiratory rate.
Observe the newborn closely for signs of magnesium toxicity for 24 to 48 hours if the mother received magnesium sulfate
close to birth.
Continue the magnesium sulfate infusion for approximately
24 hours after birth for seizure prophylaxis.
If the respirations or urinary output fall below specified levels,
or if the reflexes are diminished or absent, magnesium sulfate
should be stopped until these factors return to normal.
Keep an ampule of calcium gluconate (the antidote to
magnesium sulfate) at the bedside. The usual dose is 1 g
over about 3 minutes.
Magnesium sulfate is given I.V. via an infusion pump. A loading dose of 4 to 6 g is given over 5 minutes. Then, a maintenance dose of 2 g/hour is given.
Maternal contraindications
The only absolute contraindication is diagnosed maternal
myasthenia gravis. A history of myocardial damage or heart
block is a relative contraindication due to the effects on nerve
transmission and muscle contractility. Use extreme caution in
women with impaired renal function. The drug is eliminated by
the kidneys, so toxic magnesium levels may develop quickly.
Maternal adverse reactions
Maternal adverse reactions are dose related and can include
flushing, sweating, a feeling of warmth, nasal congestion,
nausea/vomiting, constipation, visual blurring, headache,
lethargy, weakness, slurred speech, and pulmonary edema.
Signs of developing toxicity include loss of reflexes,
urine output of less than 30 mL/hour, respiratory rate less
than 12 breaths/minute, confusion, circulatory collapse,
and respiratory paralysis. Rapid administration of large
doses may cause cardiac arrest.
Nursing considerations
daily weights
daily lab work, including hematocrit
(a rising number may signify decreasing
vascular volume), liver enzyme tests, bilirubin (rising values indicate progression of
preeclampsia), uric acid, BUN, creatinine
(reflects renal status), and platelet counts
(daily if less than 100,000/mm3; every 2
or 3 days if higher than 100,000/mm3)
medication.
Magnesium sulfate reduces the possibility of seizures by depressing the central
nervous system (see A closer look at magnesium sulfate). Hydralazine is typically
given for a persistent systolic BP of 160
mm Hg or higher or a persistent diastolic
BP of 105 mm Hg or higher. Labetalol is a
second-line I.V. medication that may be
24 Nursing made Incredibly Easy! March/April 2010
Continuously monitor the fetus and uterine activity (if the woman hasnt delivered).
Assess for vaginal bleeding and abdominal
rigidity every 15 minutes, which may indicate placental abruption.
Biceps reflex
Triceps reflex
Brachioradialis reflex
Patellar reflex
Achilles reflex
www.NursingMadeIncrediblyEasy.com
With your
help, a healthy
baby is on
the way.
Important nursing
interventions
All pregnant women, and women considering pregnancy, should be taught the importance of proper nutrition (pregnant
women need 300 extra calories per day,
and vitamin and mineral supplements)
and the importance of early and regular
prenatal care. We must reinforce to
women how imperative it is for them to
engage in good oral hygiene and receive
monitoring and management of preexisting medical conditions.
An important part of prenatal education
is instructing women about warning signs
during pregnancy. Signs and symptoms of
developing or worsening preeclampsia
may include headaches, vision changes
(blurring, spots, or double vision), swelling
of the face and hands or persistent ankle
swelling, sudden or excessive weight
gain, upper abdominal pain or nausea,
decreased urine output, and decreased fetal
movement. Educate women to contact their
healthcare provider if any of these signs or
symptoms manifest.
www.NursingMadeIncrediblyEasy.com
In summary
Buhimschi IA, Zhao G, Funai EF, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1
and albumin as biomarkers of preeclampsia. Am J Obstet
Gynecol. 2008;199(5):551.e1-e16.
Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and
metaanalysis. Am J Obstet Gynecol. 2008;198(1):7-22.
Davidson MR, Wieland Ladewig PA, London ML. Clinical
Handbook for Olds Maternal-Newborn Nursing & Womens
Health Across The Lifespan. 8th ed. Upper Saddle River, NJ:
Pearson Prentice Hall; 2008:42-50.
Fedorka PD, Heasley SW. Preeclampsia: the little-known
truth. Am Nurs Today. 2008;3(2):9-11.
Gauer R, Atlas M, Hill J. Clinical inquiries. Does low-dose
aspirin reduce preeclampsia and other maternal-fetal
complications? J Fam Pract. 2008;57(1):54-56.
London ML, Wieland Ladewig PA, Ball JW, Bindler RC.
Maternal & Child Nursing Care. 2nd ed. Upper Saddle
River, NJ: Pearson Prentice Hall; 2007:350-361.
Maternal-Neonatal Nursing Made Incredibly Easy! 2nd ed.
Philadelphia, PA: Lippincott Williams & Wilkins; 2007:
234-240.
Wu Wen SW, Chen XK, Rodger M, et al. Folic acid supplementation in early second trimester and the risk of
preeclampsia. Am J Obstet Gynecol. 2008;198(1):45.e1-e7.
Murkoff H, Mazel S. What To Expect When Youre Expecting. 4th ed. New York, NY: Workman Publishing; 2008:
413,549-550,562.
Porth CM, Matfin G. Pathophysiology: Concepts of Altered
Health States. 8th ed. Philadelphia, PA: Lippincott Williams
& Wilkins; 2009:522.
Qiu C, Coughlin KB, Frederick IO, et al. Dietary fiber
intake in early pregnancy and risk of subsequent
preeclampsia. Am J Hypertens. 2008:21(8):903-909.
Ruma M, Boggess K, Moss K, et al. Maternal periodontal
disease, systemic inflammation, and risk for preeclampsia.
Am J Obstet Gynecol. 2008;198(4):389.e1-e5.
On the Web
These online resources may be helpful to your patients and their families:
Mayo Clinic: http://www.mayoclinic.com/health/preeclampsia/DS00583
MedlinePlus: http://www.nlm.nih.gov/medlineplus/ency/article/000898.htm
National Heart, Lung, and Blood Institute: http://www.nhlbi.nih.gov/health/public/heart/hbp/hbp_
preg.htm
National Institute of Child Health and Human Development: http://www.nichd.nih.gov/health/
topics/Preeclampsia_and_Eclampsia.cfm
Preeclampsia Foundation: http://www.preeclampsia.org.
www.NursingMadeIncrediblyEasy.com